BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND Ki-67 AND Staging
62 results:

  • 1. Combined utility of ki-67 index and tumor grade to stratify patients with pancreatic ductal adenocarcinoma who underwent upfront surgery.
    Li B; Yin X; Ding X; Zhang G; Jiang H; Chen C; Guo S; Jin G
    BMC Surg; 2023 Dec; 23(1):370. PubMed ID: 38066512
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Radiomics in CT and MR imaging of the liver and pancreas: tools with potential for clinical application.
    Berbís MÁ; Godino FP; Rodríguez-Comas J; Nava E; García-Figueiras R; Baleato-González S; Luna A
    Abdom Radiol (NY); 2024 Jan; 49(1):322-340. PubMed ID: 37889265
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Solid Pseudopapillary Neoplasms of the Pancreas: Clinicopathologic Analysis and a Predictive Model.
    Chen J; Zong L; Wang P; Liu Y; Zhang H; Chang X; Lu Z; Li W; Ma Y; Yu S; Chen J
    Mod Pathol; 2023 Jun; 36(6):100141. PubMed ID: 36813115
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Gastro-Entero-pancreatic Tumors: FDG Positron Emission Tomography/Computed Tomography.
    Khatri W; Spiro E; Henderson A; Rowe SP; Solnes LB
    PET Clin; 2023 Apr; 18(2):243-250. PubMed ID: 36707371
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A relook at gastroenteropancreatic neuroendocrine tumours as per 2019 WHO classification-A tertiary centre experience.
    Ail DA; Paulose RR
    Ir J Med Sci; 2023 Oct; 192(5):2065-2070. PubMed ID: 36409421
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Venous invasion and lymphatic invasion are correlated with the postoperative prognosis of pancreatic neuroendocrine neoplasm.
    Kiritani S; Arita J; Mihara Y; Nagata R; Ichida A; Kawaguchi Y; Ishizawa T; Akamatsu N; Kaneko J; Hasegawa K
    Surgery; 2023 Feb; 173(2):365-372. PubMed ID: 36123176
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Does the Overall Survival of the Resectable Periampullary Carcinomas Correlate with High Expression of p53 and ki67?
    Rusu-Andriesi D; Trofin AM; Zabara M; Vlad N; Vasiluta C; Vasilescu A; Blaj M; Spiridon I; Cadar R; Lovin O; Crumpei F; Tarcoveanu E; Lupascu-Ursulescu C; Lupascu C
    Chirurgia (Bucur); 2022 Jun; 117(4):423-430. PubMed ID: 36049099
    [No Abstract]    [Full Text] [Related]  

  • 8. An Update on the Management of Mixed Neuroendocrine-Non-neuroendocrine Neoplasms (MiNEN).
    Jacob A; Raj R; Allison DB; Soares HP; Chauhan A
    Curr Treat Options Oncol; 2022 May; 23(5):721-735. PubMed ID: 35347561
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Correlation of 68Ga-DOTATATE uptake on PET/CT with pathologic features of cellular proliferation in neuroendocrine neoplasms.
    Karls S; Gold R; Kravets S; Wang Y; Cheng S; Perez K; Chan J; Jacene H
    Ann Nucl Med; 2021 Sep; 35(9):1066-1077. PubMed ID: 34146243
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Risk of preoperative understaging of duodenal neuroendocrine neoplasms: a plea for caution in the treatment strategy.
    Rossi RE; Milanetto AC; Andreasi V; Campana D; Coppa J; Nappo G; Rinzivillo M; Invernizzi P; Modica R; David A; Partelli S; Lamberti G; Mazzaferro V; Zerbi A; Panzuto F; Pasquali C; Falconi M; Massironi S;
    J Endocrinol Invest; 2021 Oct; 44(10):2227-2234. PubMed ID: 33651317
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. pancreatic neuroendocrine neoplasms: Clinicopathological features and pathological staging.
    Lam AK; Ishida H
    Histol Histopathol; 2021 Apr; 36(4):367-382. PubMed ID: 33305819
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. A comprehensive validation of the novel 8th edition of American Joint Committee on cancer staging manual for the long-term survivals of patients with non-functional pancreatic neuroendocrine neoplasms.
    Yang M; Zeng L; Yao WQ; Ke NW; Tan CL; Tian BL; Liu XB; Xiang B; Zhang Y
    Medicine (Baltimore); 2020 Nov; 99(46):e22291. PubMed ID: 33181635
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Grading Solid Pseudopapillary Tumors of the Pancreas: the Fudan Prognostic Index.
    Yang F; Wu W; Wang X; Zhang Q; Bao Y; Zhou Z; Jin C; Ji Y; Windsor JA; Lou W; Fu D
    Ann Surg Oncol; 2021 Jan; 28(1):550-559. PubMed ID: 32424583
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Survivals of patients with pancreatic neuroendocrine carcinomas: An in-depth analysis by the American Joint Committee on cancer 8th tumor-node-metastasis staging manual.
    Deng BY; Yang M; Wen JY; Hou SZ; Chen Y; Tian BL; Liu XB; Zhang Y
    Medicine (Baltimore); 2020 Jan; 99(3):e18736. PubMed ID: 32011453
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Multi-institutional Development and External Validation of a Nomogram to Predict Recurrence After Curative Resection of pancreatic Neuroendocrine Tumors.
    Pulvirenti A; Javed AA; Landoni L; Jamieson NB; Chou JF; Miotto M; He J; Gonen M; Pea A; Tang LH; Nessi C; Cingarlini S; D'Angelica MI; Gill AJ; Kingham TP; Scarpa A; Weiss MJ; Balachandran VP; Samra JS; Cameron JL; Jarnagin WR; Salvia R; Wolfgang CL; Allen PJ; Bassiy C
    Ann Surg; 2021 Dec; 274(6):1051-1057. PubMed ID: 31567347
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Effects of low-dose aspirin on clinical outcome and disease progression in patients with gastroenteropancreatic neuroendocrine neoplasm.
    Cavalcoli F; Pusceddu S; Zilli A; Tamagno G; Femia D; Prinzi N; Travers J; Consonni D; Ciafardini C; Conte D; Massironi S
    Scand J Gastroenterol; 2019 Sep; 54(9):1111-1117. PubMed ID: 31454281
    [No Abstract]    [Full Text] [Related]  

  • 17. Is it possible NET-redifferentiation after chemotherapy?
    Ergül N; Çermik TF; Dursun N
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(1):31-34. PubMed ID: 31122816
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Defining the Role of Lymphadenectomy for pancreatic Neuroendocrine Tumors: An Eight-Institution Study of 695 Patients from the US Neuroendocrine Tumor Study Group.
    Lopez-Aguiar AG; Zaidi MY; Beal EW; Dillhoff M; Cannon JGD; Poultsides GA; Kanji ZS; Rocha FG; Marincola Smith P; Idrees K; Beems M; Cho CS; Fisher AV; Weber SM; Krasnick BA; Fields RC; Cardona K; Maithel SK
    Ann Surg Oncol; 2019 Aug; 26(8):2517-2524. PubMed ID: 31004295
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Gastrointestinal and pancreatic neuroendocrine tumours and carcinomas; a review of rare tumour type.
    Siddiqa A; Adel H; Khan SA; Huda F; Sattar A
    J Pak Med Assoc; 2019 Apr; 69(4):533-540. PubMed ID: 31000859
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Systematic review of current prognostication systems for pancreatic neuroendocrine neoplasms.
    Teo RYA; Teo TZ; Tai DWM; Tan DM; Ong S; Goh BKP
    Surgery; 2019 Apr; 165(4):672-685. PubMed ID: 30558808
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.